β-Galactosidase-activated bioluminescent probe for in vivo tumor imaging
Chemical Communications · 2025
DOI: 10.1039/d5cc02244d ↗At a glance
Journal article in Chemical Communications, 2025. Written by Tao Hu and 5 co-authors. Institution: Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Mat…. Major MEDLINE topics: beta-Galactosidase, Luminescent Agents, Neoplasms. Cited 3 times so far (Crossref); 30 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
An activatable bioluminescent probe has been developed for monitoring β-galactosidase activity in vitro and in vivo , enabling delineation of tumors in non-transgenic mice.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China. x…
Funding
- National Natural Science Foundation of China
Cite
APA
Hu, T., Yang, Y., Zhou, B., Chen, Z., Wu, F., & Xiong, H. (2025). β-Galactosidase-activated bioluminescent probe for in vivo tumor imaging. Chemical Communications. https://doi.org/10.1039/d5cc02244d
Vancouver
Hu T, Yang Y, Zhou B, Chen Z, Wu F, Xiong H. β-Galactosidase-activated bioluminescent probe for in vivo tumor imaging. Chemical Communications. 2025. doi:10.1039/d5cc02244d
BibTeX
@article{Hu2025,
author = {Hu, Tao and Yang, Yuexia and Zhou, Bijia and Chen, Zhaoming and Wu, Fapu and Xiong, Hu},
title = {β-Galactosidase-activated bioluminescent probe for in vivo tumor imaging},
journal = {Chemical Communications},
year = {2025},
doi = {10.1039/d5cc02244d}
}
EUVIMED